Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Q4 2023 Earnings Conference Call February 28, 2024 1:00 PM ET

Company Participants

Lukas Hartwich - SVP of Finance

Rick Matros - Chief Executive Officer, President and Chair of the Board

Michael Costa - Chief Financial Officer, Secretary and Executive Vice President

Talya Nevo-Hacohen - Chief Investment Officer, Treasurer and Executive Vice President

Conference Call Participants

Farrell Granath - Bank of America

Elmer Chang - Scotiabank

Austin Wurschmidt - KeyBanc Capital Markets

Michael Griffin - Citi

Vikram Malhotra - Mizuho

Rich Anderson - Wedbush

Michael Stroyeck - Green Street

Conor Siversky - Wells Fargo

Operator

Good day, everyone. My name is Mandeep and I will be your conference operator today. At this time, I'd like to welcome everyone to the Sabra Fourth Quarter 2023 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions].

I would now like to turn the call over to Lukas Hartwich, SVP Finance. Please go ahead, Mr. Hartwich.

Lukas Hartwich

Thank you, and good morning. Before we begin, I want to remind you that we will be making forward-looking statements in our comments and in response to your questions concerning our expectations regarding our future financial position and results of operations. Including our earnings guidance for 2024 and our expectations regarding our tenants and operators and our expectations regarding our acquisition, disposition and investment plans.

These forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially including the risks listed in our Form 10-K for the year ended December 31, 2023 as well as in our earnings press release included as Exhibit 99.1 to the Form 8-K we furnished to the SEC yesterday. We undertake no obligation to update our forward-looking statements to reflect subsequent events or circumstances, and you should not assume later in the quarter that the comments we make today are still valid.

In addition, references will be made during this call to non-GAAP financial results. Investors are encouraged to review these non-GAAP financial measures as well as the explanation and reconciliation of these measures to the comparable GAAP results included on the Financials page of the Investors section of our website at sabrahealth.com. Our Form 10-K, earnings release and supplement can also be accessed in the Investors section of our website.